Journal profile

Cancer discovery

Publisher: American Association for Cancer Research
ISSN2159-8274 | 2159-8290 FormatPrint StatusCurrently indexed
Official Website Verify CrossRef

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
4.27
Citation rate 7.54 7,205 total citations
h5-index 143 h5 depth signal
Cited share 39.3% 399 of 1,016
Total citations 7,205 Citation footprint
Metric signal 7.83 External metric anchor
Self-citation 1.5% 108 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 1,391
United Kingdom 232
Germany 152
China 138
Canada 137

Citing Fields of Research

Oncology 1,639
Immunology 1,515
Cancer & Development 858
Lung Cancer 771
Cancer, Autophagy & Apoptosis 692

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 8,076 Articles tracked across the journal lifetime
Indexed publication set 1,016 399 cited publications
Last 12 months 390 32.5 publications/month
Open access share 17.2% 67 OA publications in the last year
Leading citing country United States 1,391 citing publications
Leading citing field Oncology 1,639 citing publications
Latest tracked publication 20 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v1n1, June 2011-
PubMed
v1n1, June 2011-

Research Focus & Classification

Indexed Subjects

Oncology Immunology Lung Cancer Cancer & Development Cancer, Autophagy & Apoptosis

Issuing & Sponsoring Bodies

Contributor
American Association for Cancer Research

Broad Categories

Neoplasms Immunology Lung Cancer Cancer, Autophagy & Apoptosis Cancer & Development Hematology Genetics & Genomics

MeSH Descriptors

Neoplasms

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

03
Open DOI
Natalia García-Sancha, Roberto Corchado-Cobos, Ryan Ghorayeb et al.
Breast cancer that arises in the postpartum period often carries a poor prognosis and urgently requires chemoprevention strategies, particularly for women at elevated risk. Here, we report that a single post-lactation dose of cabergoline...
05
Open DOI
Both ARPA-H and the FDA recently launched programs to help accelerate clinical trials. ARPA-H announced the SURPASS program, which is intended to create faster clinical trials that are more cost-effective and have fewer participants than...
06
Open DOI
Matthew R. Lawrence-Paul, Tien-Chi Pan, Dhruv K. Pant et al.
To evaluate the functional relevance of mutations newly detected in breast cancer metastases, we analyzed genomic data from 662 paired and ~6,000 unpaired primary and metastatic tumors. These analyses indicate that metastasis-specific mu...
09
Open DOI
Zsofia K. Stadler, Anna Maio, Aliya Khurram et al.
Age at diagnosis among patients with cancer is a predictor of pathogenic germline variant prevalence, yet age thresholds often misclassify genetic risk. We performed germline sequencing of 39,184 unselected patients with solid malignanci...
10
DOI 10.1158/2159-8290.cd-nw2026-0094

Nobel Prize Spotlights Optogenetics’ Reach into Cancer

Open DOI
Optogenetics, the Nobel-winning technology developed for neuroscience, is giving cancer researchers an unusually precise way to probe how tumors respond to signals from the nervous system. Scientists are also adapting optogenetics to bui...

Bibliographical & Catalog Notes

Print issues ceased with v. 10, no. 12 (Dec. 2020).

Also issued online.